Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Elnaghi KAEA, Alghanmi HA, Elsamany SA, Almarzoki F, et al. Hormonal-Receptors-Positive and HER2-Negative Patients with Metastatic Breast Cancer Treated with First-Line Palbociclib and Hormonal Therapy: Impact of First-Cycle Neutropenia and Dose Reduction on Therapeutic Outcome. Breast J 2023;2023:8994954.
PMID: 37664544


Privacy Policy